More News

Novel smart mRNA harnesses pre-existing immunity in 99% of world population

Jim Cornall -
CancerVax, Inc., the developer of a universal cancer treatment platform that “tricks” the body’s immune system into fighting cancer,...

Asthma: New mechanism of action curbs asthma inflammatory response

Jim Cornall -
A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a...

Alzheimer’s Drug Discovery Foundation and Michael J. Fox Foundation launch $5m partnership

Jim Cornall -
The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) have announced a...

New approach to developing non-opioid painkillers

Jim Cornall -
An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone...

Atopic dermatitis trial meets primary endpoint

Jim Cornall -
InnoCare Pharma has announced that registrational phase III clinical study results of novel TYK2 (tyrosine kinase 2) inhibitor soficitinib...

Key to immunotherapy for intractable brain tumours discovered

Jim Cornall -
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune brakes exploited by tumours...

Fast Track Designation for colorectal cancer treatment

Jim Cornall -
SOTIO Biotech has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to...

AI helps predict which DNA sequences bind to each other

Jim Cornall -
Researchers have demonstrated a novel AI model that can predict which DNA molecules bind with which other DNA molecules....

Boost for Niagen’s NAD+ programme

Jim Cornall -
Niagen Bioscience, Inc. has announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly...

Base to Base biotech podcast 68: Water from air for pharma and beyond

Jim Cornall -
This week, we have a conversation with Kyle Cordova, founder and CEO of AquaPoro. Base to Base biotech podcast 68:...

New phase 1 data show potential for neurodegenerative disease treatment

Jim Cornall -
Vandria has presented new data from the multiple ascending dose part of its phase 1 study of VNA-318. The data,...

Metabolic syndrome linked to faster brain ageing

Jim Cornall -
Metabolic syndrome is defined as having at least three of five conditions: excess body fat around the waist, high...

Bowel cancer samples could boost understanding of other killer diseases

Jim Cornall -
Bowel cancer screening samples could also be used for crucial research into other major health conditions, a new study...

FDA clearance for non-muscle invasive bladder cancer treatment

Jim Cornall -
UroGen Pharma Ltd. has announced that the U.S. Food and Drug Administration (FDA) cleared the company's Investigational New Drug...

Scientists uncover genetic clues from tumour-prone reptile that could advance cancer research

Jim Cornall -
A new study, led by experts at the University of Nottingham in the UK, suggests a pet gecko with...

AI technology detects early warning signs of cerebrovascular disease at home

Jim Cornall -
Cerebrovascular disease can lead to serious aftereffects if treatment is delayed, but it is difficult to detect before symptoms...

Positive results from plantar fibromatosis trial

Jim Cornall -
Keenova Therapeutics plc has announced positive results from its phase 3 clinical trial of XIAFLEX (collagenase clostridium histolyticum) for...

KAIST brings microbial cell factories one step closer

Jim Cornall -
The era of biomanufacturing, where microbes and not petroleum produce chemical products, is one step closer. A KAIST research team...

$18m investment in malaria, TB and NTD projects

Jim Cornall -
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately $18m in six R&D projects...

Anticancer “nanoswitch” technology developed

Jim Cornall -
A research team led by Yoosoo Yang (Department of Integrative Biotechnology) at SKKU, in collaboration with the Korea Institute...

Epigenetic mapping provides deeper insight into leukaemia

Jim Cornall -
Researchers at Karolinska Institutet in Sweden and Kyoto University in Japan have identified new subgroups of the blood cancer...